The Charles River assay development and screening department offers a unique combination of target class and cell biology expertise together with state-of-the-art instrumentation to provide services tailored to your requirements.

We provide a collaborative environment and work closely with our teams in medicinal chemistry, ADME, structural biology and fragment-based drug discovery to deliver within challenging timelines.

Phenotypic Screening Using Patient-Derived Human Primary Cells

This poster describes the application of PhenoFocus platform as a phenotypic screening program for target and drug discovery. Download now »

I need to...